Norepinephrine dose and concentration reporting: a closer look at the fine print
Intensive Care Med
.
2024 Jun;50(6):1006-1007.
doi: 10.1007/s00134-024-07425-4.
Epub 2024 Apr 10.
Authors
Isabelle Goyer
1
,
Bruno Levy
2
3
,
Marc Leone
4
Affiliations
1
Department of Pharmacy, Service de Pharmacie, CHU de Caen, Avenue de la Côte de Nacre, 14000, Caen, France. goyer-i@chu-caen.fr.
2
INSERM U1116, Faculté de Médecine, Vandoeuvre-les-Nancy, France.
3
Université de Lorraine, Nancy, France.
4
Service d'anesthésie et de Réanimation, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
PMID:
38598127
DOI:
10.1007/s00134-024-07425-4
No abstract available
Publication types
Letter
Editorial
MeSH terms
Dose-Response Relationship, Drug
Humans
Norepinephrine* / therapeutic use
Vasoconstrictor Agents / therapeutic use
Substances
Norepinephrine
Vasoconstrictor Agents